Keyphrases
3′-untranslated Region (3′-UTR)
7%
Biogenesis
7%
Effective Treatment
7%
Fatty Liver
7%
Glucose Production
23%
Hepatic Insulin Resistance
7%
Hepatic Lipogenesis
15%
Hepatosteatosis
100%
High-fat Diet
7%
Human Hepatocytes
15%
Human Liver
7%
Hyperglycemia
100%
Inhibitory Effect
15%
Insulin Receptor
7%
Insulin Resistance
15%
Insulin Signaling
100%
Lay Summary
7%
Lipid Accumulation
7%
Lipid Production
15%
Lipids
15%
Lipogenesis
100%
Liver
38%
Major Complications
7%
Minicircle Vector
7%
MiR-206
100%
Mouse Hepatocytes
7%
Non-alcoholic Fatty Liver Disease (NAFLD)
7%
Novel Therapeutics
7%
Obese Men
7%
Obese Mice
30%
Obesity
7%
Pathophysiology
7%
Phosphorylation
7%
Potent Inhibitor
7%
Protein Tyrosine Phosphatase 1B (PTP1B)
23%
PTPN1
7%
Receptor Subtypes
23%
Reintroduction
7%
Therapeutic Agents
7%
Therapeutic Effect
7%
Type 2 Diabetes Mellitus (T2DM)
7%
Medicine and Dentistry
Biogenesis
8%
Disease
8%
Fatty Liver
100%
Gluconeogenesis
16%
Hepatocyte
16%
High Fat Food
8%
Hyperglycemia
100%
Insulin Receptor
8%
Insulin Resistance
16%
Insulin Signaling
100%
Lipid Storage
8%
Lipogenesis
100%
Maturity Onset Diabetes of the Young
8%
microRNA
100%
Nonalcoholic Fatty Liver
8%
Pathophysiology
8%
Protein Tyrosine Phosphatase 1B
25%
Therapeutic Agent
8%
Therapy Effect
8%
Untranslated Region
8%
Biochemistry, Genetics and Molecular Biology
Biogenesis
8%
Gluconeogenesis
16%
Hepatocyte
16%
Hyperglycemia
100%
Insulin Receptor
8%
Insulin Resistance
16%
Insulin Signaling
100%
Lipid
33%
Lipid Storage
8%
Lipogenesis
100%
MicroRNA
100%
Minicircle
8%
Mouse Mutant
33%
Protein Tyrosine Phosphatase
25%
Transcription
8%
Untranslated Region
8%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
8%
Fatty Liver
100%
Hyperglycemia
100%
Insulin Receptor
8%
Insulin Resistance
16%
microRNA
100%
Mouse Mutant
33%
Non Insulin Dependent Diabetes Mellitus
8%
Nonalcoholic Fatty Liver
8%
Pathophysiology
8%
Protein Tyrosine Phosphatase 1B
25%
Therapeutic Effect
8%